Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,421.87
(
0.28%
)
US TECH 100
28,448.40
(
0.56%
)
Dow Jones
49,526.84
(
-0.47%
)
Brent Oil
104.47
(
-1.22%
)
Bitcoin
78,861.26
(
-2.02%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: Carboat post# 270589

Friday, 08/19/2016 6:11:56 AM

Friday, August 19, 2016 6:11:56 AM

Post# of 347009
Avid will not split while under Peregrine control. It will likely be split after the final buyout for $150 Billion and for one to seek that would seem like their investment here is for Avid... which makes no sense because there are plenty of manufacturing biotech to invest in .. So now we move full circle and must ask how many PS Targeting biotechs to invest in ? ...that have 100% control IP rights?

Only one

Peregrine Pharmaceuticals the only one

This is the reason all are here

IP control is the reason for Fargo sabotage

Avid will not, never be split up ... while Peregrine has control.

Avid going to be self sufficient soon anyhow...big contracts on their way.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote